Resistance beta-lactams and glycopeptides

studied byStudied by 0 people
0.0(0)
Get a hint
Hint

three major mechanisms of antibiotic resistance

1 / 11

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

12 Terms

1

three major mechanisms of antibiotic resistance

1. Modify the drug  

2. Modify the target  

3. Pump the drug out with efflux pumps  

New cards
2

Understand the importance of binding PBP2a.

For example, PBP2a is found in MRSA, which leads to resistance to most beta lactams due to low affinity for PBP2a, but ceftaroline binds and inhibits transpeptidation by PBP2a.

New cards
3

For the types of beta-lactamases understand which classes are serine-based and which class is a metallo-enzyme

Serine Beta Lactamases (Classes A,C,D)
Zinc Beta Lactamases (Class B)

New cards
4

the strategies used to overcome resistance via beta-lactamase inhibitors

Slow substrates
Suicide substrates

New cards
5

Suicide substrates

Clavulanate, Sulbactam, Tazobactam
Used on combo w beta lactams to inactivate beta lactamses

New cards
6

How making beta-lactams that are slow substrates.

Structural modifications in the acyl side chains of B lactam antibiotics to build in slow processing by B lactamases

New cards
7

Why are lactamases such as NDM-1 effective at hydrolyzing beta-lactams that were modified to be slow substrates for ser based lactamases?

Divalent ions in the active site

mechanism doesn’t rely on a serine residue or a covalent intermediate (like in serine-based beta-lactamases), MBLs can easily hydrolyze beta-lactams that were chemically modified to resist serine enzymes

New cards
8

Why do Beta-lactamase inhibitors such as Clavulonic acid (Clavulonate), sulbactam, tazobactam, and vabomere need to be co-administered with a beta lactam antibiotic

inhibit serine-based beta-lactamases but need to be co-administered with a beta lactam antibiotic because they don’t have sufficient antibacterial activity on their own.  

New cards
9

vancomycin activates

both VanB and VanA where other glycopeptides such as teicoplanin and Dalbavancin do not activate VanB

(vancomycin is not effective against bacteria with VanA or VanB genes.)

New cards
10

Van C phenotype uses ___ instead of D-Lac

D-Ser

New cards
11

What distinguishes Ortivancin

Does not activate VanA, VanB, and VanC

New cards
12

Be familiar with the VanA, VanB, and resistance types.

  • VanA is the most clinically significant because of its high-level resistance and plasmid-mediated spread.

  • VanB resistance is limited to vancomycin, making teicoplanin a possible alternative.

  • VanC is intrinsic and poses less of a threat, but still requires careful consideration in treatment.

New cards

Explore top notes

note Note
studied byStudied by 352 people
... ago
5.0(1)
note Note
studied byStudied by 44 people
... ago
4.0(1)
note Note
studied byStudied by 34 people
... ago
4.5(2)
note Note
studied byStudied by 8 people
... ago
5.0(1)
note Note
studied byStudied by 141 people
... ago
4.3(7)
note Note
studied byStudied by 18 people
... ago
5.0(1)
note Note
studied byStudied by 24 people
... ago
5.0(1)
note Note
studied byStudied by 9 people
... ago
5.0(3)

Explore top flashcards

flashcards Flashcard (102)
studied byStudied by 23 people
... ago
5.0(1)
flashcards Flashcard (31)
studied byStudied by 3 people
... ago
5.0(1)
flashcards Flashcard (71)
studied byStudied by 26 people
... ago
5.0(1)
flashcards Flashcard (230)
studied byStudied by 6 people
... ago
5.0(1)
flashcards Flashcard (82)
studied byStudied by 3 people
... ago
5.0(1)
flashcards Flashcard (20)
studied byStudied by 1 person
... ago
5.0(1)
flashcards Flashcard (23)
studied byStudied by 97 people
... ago
5.0(1)
flashcards Flashcard (404)
studied byStudied by 4 people
... ago
5.0(3)
robot